Beginning Jan. 1, 2021, Bioventus’ Durolane, Gelsyn-3 and Supartz FX will be included among the four preferred knee osteoarthritis treatment options on the formulary for CVS Caremark members.
Durolane is a single-injection hyaluronic acid-based joint-fluid treatment for patients. Gelsyn-3 is a hyaluronic acid-based joint-fluid treatment requiring three injections, and Supartz is a five-injection hyaluronic acid-based joint-fluid treatment.
More articles on surgery centers:
10 recent ASC leadership moves
Virginia ASC takes infection prevention to new level — 3 insights
Surgery Partners goes all-in on cardiology — 5 quotes on its quarterly performance
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
